Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity.
Journal
Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624
Informations de publication
Date de publication:
10 May 2024
10 May 2024
Historique:
medline:
10
5
2024
pubmed:
10
5
2024
entrez:
10
5
2024
Statut:
ppublish
Résumé
Chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of neurological autoimmune diseases is promising, but CAR T cell kinetics and immune alterations after treatment are poorly understood. Here, we performed single-cell multi-omics sequencing of paired cerebrospinal fluid (CSF) and blood samples from patients with neuromyelitis optica spectrum disorder (NMOSD) treated with anti-B cell maturation antigen (BCMA) CAR T cells. Proliferating cytotoxic-like CD8
Identifiants
pubmed: 38728414
doi: 10.1126/sciimmunol.adj9730
doi:
Substances chimiques
Receptors, Chimeric Antigen
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM